Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR‐1) Reveals Inverse NOR‐1 Agonists

The neuron derived orphan receptor (NOR‐1, NR4A3) is among the least studied nuclear receptors. Its physiological role and therapeutic potential remain widely elusive which is in part due to the lack of chemical tools that can directly modulate NOR‐1 activity. To probe the possibility of pharmacological NOR‐1 modulation, we have tested a drug fragment library for NOR‐1 activation and repression. Despite low hit‐rate (<1 %), we have obtained three NOR‐1 ligand chemotypes one of which could be rapidly expanded to an analogue comprising low micromolar inverse NOR‐1 agonist potency and altering NOR‐1 regulated gene expression in a cellular setting. It confirms druggability of the transcription factor and may serve as an early tool to assess the role and potential of NOR‐1.